Blaine Cobban
For individuals self-administering peptide-based medications who require precise dosage calculations and prioritize offline data privacy.
ShotTrackr: GLP-1 & PeptideSnapshot
Who is Blaine Cobban?
Providing specialized tracking and dosage calculation tools for individuals managing complex peptide and GLP-1 medication regimens.
Target audience
Portfolio
Last updated
ShotTrackr: GLP-1 & Peptide
v1.6.0
8mo ago
Publisher DNA
What defines Blaine Cobban?
Publisher DNA
Primary focus
Medical utility apps for peptide therapy management
Scale
indie
Target audience
Individuals self-administering peptide-based medications who require precise dosage calculations and prioritize offline data privacy.
Signature Patterns
- •Focus on specialized medical dosage calculations and inventory management.
- •Privacy-centric architecture with no account requirements or data mining.
- •Monetization via a one-time paid purchase model rather than recurring subscriptions.
- •High-frequency update cadence focused on refining utility features like reconstitution calculators.
Portfolio momentum
Maintains an intense development pace with 12 updates to the flagship title in the last 6 months, including a major release within the last 30 days.
Portfolio
What does Blaine Cobban ship?
Apps
1 app analysed
Offline-first architecture ensures complete data privacy
- The intuitive tracking interface for health metrics makes daily logging feel efficient for older users
- Critical bugs during the initial setup process prevent new users from adding inventory or vials
Single-market publisher, every app ships only to United States.
Based on 1 of 1 app with localized market data · last scanned .
Americas (1)
- United States1 / 1
Core markets (1/1 apps)
User Sentiment
How do users feel about their apps?
1
Positive apps
0
Neutral / mixed
0
Negative apps
75/100
Avg sentiment score
Rivals
Who does Blaine Cobban compete with?
The rivals identified
Nemeses(1)
Both applications provide dosage calculation tools for peptide users, creating direct competition for the same user base.
Contenders(10)
Both apps target users managing peptide and GLP-1 regimens with built-in reconstitution calculators. Regimen competes by offering a freemium model and broader compound support compared to the paid, privacy-first approach of ShotTrackr.
PepCalc serves as a dedicated calculation tool for reconstitution, mirroring the core utility of ShotTrackr without additional tracking features.
Both apps target users managing GLP-1 medication regimens, with Glippy offering a free, community-integrated alternative to the paid, privacy-focused model of ShotTrackr: GLP-1 & Peptide.
Both apps target users managing peptide regimens, including GLP-1 and hormone therapies, by providing specialized tools for dosage calculation and progress monitoring.
Both apps target users managing peptide and GLP-1 regimens, offering overlapping functionality for dosage calculation and injection logging.
Both apps target individuals managing peptide regimens, competing directly on dosage calculation and administration tracking functionality.
Both apps target users managing GLP-1 peptide regimens, with overlapping functionality in injection logging and dosage tracking.
Both apps target users managing injectable peptide regimens, with Injectly offering a free, sync-capable alternative to the paid, local-only model of ShotTrackr.
Both applications target users managing peptide and GLP-1 regimens, providing reconstitution calculators and dosage management tools for self-administered therapies.
Both apps target individuals managing peptide and GLP-1 regimens with overlapping core functionality including reconstitution calculators and inventory management.
Same space(9)
Himcules specializes in testosterone protocol management, serving a specific subset of the peptide and hormone user base.
DoseRx offers a privacy-focused, offline-first utility for peptide reconstitution that aligns with the data-privacy stance of ShotTrackr.
PeptidePal targets a broader range of research peptides and TRT protocols than the GLP-1 focus of ShotTrackr.
GLPTracker functions as a digital logbook for GLP-1 patients, providing a free alternative for basic medication and symptom tracking.
DreamMe uses gamification to maintain medication adherence, offering a different engagement model than the utility-focused ShotTrackr.
MeAgain provides a centralized hub for nutrition and symptom logging that expands beyond the medication-only focus of ShotTrackr.
Peptide Tracker provides a protocol management system for complex stacks, contrasting with the simpler utility of ShotTrackr.
Shotsy provides clinical-grade medication level visualization that contrasts with the manual tracking approach of ShotTrackr.
Pep AI focuses on inventory and note-keeping for research peptides, serving users who need more than just dosage calculation.
New entrants(1)
Revio combines medication tracking with nutrition and fiber logging, targeting users who want a broader health management tool.
The Analyst's Read
The bottom line on Blaine Cobban
Bottom line
Users report: Blaine Cobban is a specialized indie developer successfully targeting the GLP-1 and peptide tracking niche by prioritizing privacy and utility over data-harvesting. The high update velocity and focused feature set signal a strong product-market fit for users seeking technical medical tools.
Frequently asked questions
How many apps does Blaine Cobban publish?
What kind of apps does Blaine Cobban make?
What is Blaine Cobban's top app?
In how many countries are Blaine Cobban's apps available?
What fed this analysis
- Apps analyzed:
- 1
- With full intel:
- 0
- With overview:
- 1
- Website scraped:
- yes
- Social presence:
- no